Pharmaceutical

STAT+: CRISPR? Nah. A new startup bets on an old approach to gene editing

STAT+: CRISPR? Nah. A new startup bets on an old approa...

Mar 19, 2023

Giving an old genome-editing tool a new twist, Seamless Therapeutics launches ba...

STAT+: Takeda autoimmune therapy shows effectiveness in key trial

STAT+: Takeda autoimmune therapy shows effectiveness in...

Mar 19, 2023

‘We’ll look back and say that this was a bargain.’ Takeda reveals first data fro...